ACCESSION: MSBNK-SMB_Measured-HSA001P0160013
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'16_posi_3398': {'bp': 1263520.0, 'sum': 1557793.0}, '15_posi_3398': {'bp': 846267.0, 'sum': 1089622.0}, '7_posi_3358': {'bp': 596079.0, 'sum': 821371.0}, '14_posi_3379': {'bp': 1162029.0, 'sum': 1422847.0}, '11_posi_3359': {'bp': 1035894.0, 'sum': 1322110.0}, '17_posi_3358': {'bp': 750089.0, 'sum': 1002931.0}, '8_posi_3317': {'bp': 655700.0, 'sum': 912255.0}, '8_posi_3399': {'bp': 1146778.0, 'sum': 1455503.0}, '4_posi_3358': {'bp': 1100134.0, 'sum': 1382999.0}, '6_posi_3359': {'bp': 1092213.0, 'sum': 1349567.0}, '5_posi_3376': {'bp': 1018913.0, 'sum': 1317150.0}, '3_posi_3356': {'bp': 1182206.0, 'sum': 1496908.0}, '12_posi_3380': {'bp': 1045648.0, 'sum': 1312051.0}, '1_posi_3338': {'bp': 797333.0, 'sum': 1080355.0}, '10_posi_3337': {'bp': 655687.0, 'sum': 937706.0}, '9_posi_3380': {'bp': 1116091.0, 'sum': 1403036.0}, '19_posi_3464': {'bp': 1163840.0, 'sum': 1446467.0}, '18_posi_3422': {'bp': 1009272.0, 'sum': 1274363.0}, '17_posi_3441': {'bp': 876053.0, 'sum': 1125313.0}, '2_posi_3303': {'bp': 673593.0, 'sum': 946661.0}, '5_posi_3296': {'bp': 735082.0, 'sum': 971763.0}}
COMMENT: RETENTION_TIME_STDEV 0.084
COMMENT: PRECURSOR_M/Z_RAW 160.096530
COMMENT: PRECURSOR_M/Z_STDEV 0.000042
COMMENT: PRECURSOR_IN_MS1 mz 160.096867; int 95.963; delta(ppm) 1.426811
COMMENT: PROPOSED_CHARGE_STATE +1; mz 161.100176; int 6.435; cor 0.919
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.302; C7H13NO3; [M+H]+; delta(ppm) 0.301717
COMMENT: PROPOSED_MF MS-FINDER 4.097; C7H13NO3; [M+H]+; delta(ppm) 0.295321
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.009; C7H13NO3; [M+H]+; delta(ppm) 0.295321
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H13NO3; [M+H]+; delta(ppm) 0.295321
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.717; C7H13NO3; [M+H]+; delta(ppm) 0.295321
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.739; C6H17NSi2; [M+H]+; delta(ppm) -285413.831585
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.543; C5H11N4O2; [M+H]+; delta(ppm) 8.681967
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H13NO3; [M+H]+; delta(ppm) 0.295321
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 14.000; QRIAWCUEIMQLGG-UHFFFAOYSA-N; C7H13NO3; 2-(4-aminotetrahydro-2H-pyran-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.844; FSMRMYVITPBGGD-UHFFFAOYNA-N; [M+H]+; OC1CC(O)C2(O)CCC1N2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.750; MUNWAHDYFVYIKH-DBJGSTHZNA-N; [M+H]+; C[N+]1(C)CC(O)C[C@@H]1C([O-])=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.737; YNOWULSFLVIUDH-UHFFFAOYSA-N; [M+H]+; C[N+](C)(C)CC(=O)CC([O-])=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.714; SYOMWKCHPLIBRY-UUGMBHAONA-N; [M+H]+; O[C@H]1[C@H]2CC[C@H](N2)[C@@H](O)[C@@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.682; XOCBOVUINUHZJA-UHFFFAOYNA-N; [M+H]+; OC1CC2CCC(O)(N2)C1O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.389; XOCBOVUINUHZJA-UHFFFAOYNA-N; [M+H]+; Calystegin A3
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.377; YNOWULSFLVIUDH-UHFFFAOYSA-N; [M+H]+; 3-Dehydrocarnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.291; ZRQXMKMBBMNNQC-UHFFFAOYSA-N; [M+H]+; Isovalerylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.280; MUNWAHDYFVYIKH-DBJGSTHZNA-N; [M+H]+; 4-Hydroxystachydrine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.273; IHYJTAOFMMMOPX-UHFFFAOYNA-N; [M+H]+; N-Acetylvaline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.247; TZZSWAXSIGWXOS-UHFFFAOYSA-N; [M+H]+; 5-Acetamidovalerate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.239; HOACIBQKYRHBOW-UHFFFAOYNA-N; [M+H]+; 2-Methylbutyrylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.203; FSMRMYVITPBGGD-UHFFFAOYNA-N; [M+H]+; Calystegine A7
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.195; NYZBWOSRZJKQAI-UHFFFAOYSA-N; [M+H]+; Valerylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.180; YOBNKFROEGVQPW-UHFFFAOYNA-N; [M+H]+; Calystegine A6
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.124; DQWMCYRFSUZYJX-SOFGYWHQSA-N; [M+H]+; UNPD110432
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.106; XYDFSCGFCFYWNY-UHFFFAOYNA-N; [M+H]+; methyl 4-hydroxypiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.093; KQOGWNKGUKQZHP-UHFFFAOYNA-N; [M+H]+; methyl 4-hydroxypiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.087; AXSWEYXUHSNDLV-VTPUDEAPNA-N; [M+H]+; Calystegine A5
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.076; SYOMWKCHPLIBRY-UUGMBHAONA-N; [M+H]+; 2alpha,3beta,4alpha-Trihydroxynortropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.066; KKBQWQJVUYTRDO-UHFFFAOYNA-N; [M+H]+; methyl 5-hydroxypiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.061; DJMIFDZBCUUQJN-MZQZIECVNA-N; [M+H]+; 3-Hydroxystachydrine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.060; ROVDTLLPFWAZJC-UHFFFAOYNA-N; [M+H]+; Medicanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.054; WTXSKBFLNOWQNF-UHFFFAOYNA-N; [M+H]+; methyl 3-hydroxypiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.043; JPBFOLUCPZHDQU-BIWBQAJPNA-N; [M+H]+; UNPD120605
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.035; MOPMNYGCKDMKSI-NTYURTKENA-N; [M+H]+; UNPD127878
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.027; ABGLVXROVAEWNL-IOMOGOHMNA-N; [M+H]+; UNPD106296
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.027; NRRIAWBEPOWFOG-IOMOGOHMNA-N; [M+H]+; UNPD11961
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.024; JMHQESARJMGVCZ-GDVGLLTNSA-N; [M+H]+; ethyl (2S)-4-hydroxypyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.019; BSILTUUPJBINLI-UHFFFAOYNA-N; [M+H]+; Methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.981; LCRFCICIBIZKQT-MZQZIECVNA-N; [M+H]+; UNPD85694
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.974; MVBWEDQLROJLNC-UHFFFAOYNA-N; [M+H]+; methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.972; VZDTVUQVDDMTIV-UHFFFAOYSA-N; [M+H]+; 4-methylmorpholin-2-yl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.960; SQDCKWZBSHPVFA-FGDISIECNA-N; [M+H]+; UNPD110530
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.960; UHJUDIZEJLVXPU-KVHZBMRTNA-N; [M+H]+; UNPD66662
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.960; WZZMBPRDBKYFMA-MZQZIECVNA-N; [M+H]+; UNPD28201
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.944; ZJARKWCZWLXHKE-UHFFFAOYSA-N; [M+H]+; 3-(1,4-dioxan-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.927; RTRUEBYROMJFNU-UHFFFAOYSA-N; [M+H]+; 2-(2,2-dimethylpropanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.920; LXEVWVMXUCHVCO-UHFFFAOYNA-N; [M+H]+; methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.920; BMZJPVSGERKRHP-RRKCRQDMSA-N; [M+H]+; 1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.920; QRIAWCUEIMQLGG-UHFFFAOYSA-N; [M+H]+; 2-(4-aminooxan-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.920; RLKJCGBSXJCYIQ-UHFFFAOYSA-N; [M+H]+; 3-(2-methylpropanamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.914; DNFNIHHMOVZOCZ-UHFFFAOYNA-N; [M+H]+; methyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.904; DTIMTCJMOWXMGT-UHFFFAOYNA-N; [M+H]+; N-butyrylalanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.904; QBAOJDDQEIVZJA-UHFFFAOYSA-N; [M+H]+; 2-(methylamino)-5-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.895; ROECQVJPXMAZDK-UHFFFAOYSA-N; [M+H]+; 6-methoxy-hexahydrofuro[3,2-b]furan-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.885; CMMYGCUEJWTBCG-UHFFFAOYSA-N; [M+H]+; 2-Propenamide, N-(2,2-dimethoxyethyl)-
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.868; BYJPRUDFDZPCBH-UHFFFAOYSA-N; [M+H]+; N-[2-(2-hydroxyethoxy)ethyl]prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DQWMCYRFSUZYJX-SOFGYWHQSA-N; [M+H]+; UNPD110432
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.935; TZZSWAXSIGWXOS-UHFFFAOYSA-N; [M+H]+; 5-Acetamidovalerate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.928; JMHQESARJMGVCZ-GDVGLLTNSA-N; [M+H]+; ethyl (2S)-4-hydroxypyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; MUNWAHDYFVYIKH-DBJGSTHZNA-N; [M+H]+; 4-Hydroxystachydrine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; NRRIAWBEPOWFOG-IOMOGOHMNA-N; [M+H]+; UNPD11961
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.885; DTIMTCJMOWXMGT-UHFFFAOYNA-N; [M+H]+; N-butyrylalanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.885; RLKJCGBSXJCYIQ-UHFFFAOYSA-N; [M+H]+; 3-(2-methylpropanamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.879; ROVDTLLPFWAZJC-UHFFFAOYNA-N; [M+H]+; Medicanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.879; WZZMBPRDBKYFMA-MZQZIECVNA-N; [M+H]+; UNPD28201
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.878; KQOGWNKGUKQZHP-UHFFFAOYNA-N; [M+H]+; methyl 4-hydroxypiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; KKBQWQJVUYTRDO-UHFFFAOYNA-N; [M+H]+; methyl 5-hydroxypiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; MVBWEDQLROJLNC-UHFFFAOYNA-N; [M+H]+; methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; JPBFOLUCPZHDQU-BIWBQAJPNA-N; [M+H]+; UNPD120605
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; LCRFCICIBIZKQT-MZQZIECVNA-N; [M+H]+; UNPD85694
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.871; XYDFSCGFCFYWNY-UHFFFAOYNA-N; [M+H]+; methyl 4-hydroxypiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.871; ABGLVXROVAEWNL-IOMOGOHMNA-N; [M+H]+; UNPD106296
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.863; BSILTUUPJBINLI-UHFFFAOYNA-N; [M+H]+; Methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; QBAOJDDQEIVZJA-UHFFFAOYSA-N; [M+H]+; 2-(methylamino)-5-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.840; DJMIFDZBCUUQJN-MZQZIECVNA-N; [M+H]+; 3-Hydroxystachydrine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.833; YNOWULSFLVIUDH-UHFFFAOYSA-N; [M+H]+; 3-Dehydrocarnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.813; LXEVWVMXUCHVCO-UHFFFAOYNA-N; [M+H]+; methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.813; WTXSKBFLNOWQNF-UHFFFAOYNA-N; [M+H]+; methyl 3-hydroxypiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.812; DNFNIHHMOVZOCZ-UHFFFAOYNA-N; [M+H]+; methyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; FSMRMYVITPBGGD-UHFFFAOYNA-N; [M+H]+; Calystegine A7
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; XOCBOVUINUHZJA-UHFFFAOYNA-N; [M+H]+; Calystegin A3
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; YOBNKFROEGVQPW-UHFFFAOYNA-N; [M+H]+; Calystegine A6
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; AXSWEYXUHSNDLV-VTPUDEAPNA-N; [M+H]+; Calystegine A5
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; SYOMWKCHPLIBRY-UUGMBHAONA-N; [M+H]+; 2alpha,3beta,4alpha-Trihydroxynortropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.802; QRIAWCUEIMQLGG-UHFFFAOYSA-N; [M+H]+; 2-(4-aminooxan-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.794; BMZJPVSGERKRHP-RRKCRQDMSA-N; [M+H]+; 1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; HOACIBQKYRHBOW-UHFFFAOYNA-N; [M+H]+; 2-Methylbutyrylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; NYZBWOSRZJKQAI-UHFFFAOYSA-N; [M+H]+; Valerylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; ZRQXMKMBBMNNQC-UHFFFAOYSA-N; [M+H]+; Isovalerylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; RTRUEBYROMJFNU-UHFFFAOYSA-N; [M+H]+; 2-(2,2-dimethylpropanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.774; SQDCKWZBSHPVFA-FGDISIECNA-N; [M+H]+; UNPD110530
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.750; BYJPRUDFDZPCBH-UHFFFAOYSA-N; [M+H]+; N-[2-(2-hydroxyethoxy)ethyl]prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.747; MOPMNYGCKDMKSI-NTYURTKENA-N; [M+H]+; UNPD127878
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.711; VZDTVUQVDDMTIV-UHFFFAOYSA-N; [M+H]+; 4-methylmorpholin-2-yl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.635; ROECQVJPXMAZDK-UHFFFAOYSA-N; [M+H]+; 6-methoxy-hexahydrofuro[3,2-b]furan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.583; ZJARKWCZWLXHKE-UHFFFAOYSA-N; [M+H]+; 3-(1,4-dioxan-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.516; IHYJTAOFMMMOPX-UHFFFAOYNA-N; [M+H]+; N-Acetylvaline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.516; CMMYGCUEJWTBCG-UHFFFAOYSA-N; [M+H]+; 2-Propenamide, N-(2,2-dimethoxyethyl)-
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.516; UHJUDIZEJLVXPU-KVHZBMRTNA-N; [M+H]+; UNPD66662
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.638; ZRQXMKMBBMNNQC-UHFFFAOYSA-N; [M+H]+; 2-(3-methylbutanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.301; IHYJTAOFMMMOPX-LURJTMIESA-N; [M+H]+; (2S)-2-acetamido-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.095; HOACIBQKYRHBOW-UHFFFAOYSA-N; [M+H]+; 2-(2-methylbutanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.897; YUYHRSGXZZVNMS-UHFFFAOYSA-N; [M+H]+; 3-morpholin-4-ylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.706; ACNRTYKOPZDRCO-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(2-oxoethyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.561; TZZSWAXSIGWXOS-UHFFFAOYSA-N; [M+H]+; 5-acetamidopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.353; NYZBWOSRZJKQAI-UHFFFAOYSA-N; [M+H]+; 2-(pentanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.298; ZAKAONRTRWRIJT-UHFFFAOYSA-N; [M+H]+; ethyl 3-ethoxy-3-iminopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.261; LTMOFXOWXXOMEZ-UHFFFAOYSA-N; [M+H]+; methyl 2-morpholin-4-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.254; XOCBOVUINUHZJA-UHFFFAOYSA-N; [M+H]+; 8-azabicyclo[3.2.1]octane-1,2,3-triol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; CQHODIYUGCTFHA-SOFGYWHQSA-N; [M+H]+; ethyl (4E)-4-hydroxyiminopentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; WEJKUVSYIGOBAR-UHFFFAOYSA-N; [M+H]+; 2-morpholin-4-ylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.135; BSYFPUSAWVWWDG-LURJTMIESA-N; [M+H]+; (2S)-2-acetamidopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; JMHQESARJMGVCZ-RITPCOANSA-N; [M+H]+; ethyl (2S,4R)-4-hydroxypyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; NYGTWXWGPWMMJX-UHFFFAOYSA-N; [M+H]+; 4-oxo-4-(propylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.074; GWSSURYRYDYOGR-UHFFFAOYSA-N; [M+H]+; 6-(methylamino)-6-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.063; LIEYNOJBDICZQM-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-morpholin-4-ylpropan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; UMYVUUWWXGDGCP-ZCFIWIBFSA-N; [M+H]+; 3-[(2R)-morpholin-2-yl]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; QGYOYSNYGPBMAT-UHFFFAOYSA-N; [M+H]+; ethyl 2-(3-hydroxyazetidin-3-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; IFPUIUKCHWNXJK-UHFFFAOYSA-N; [M+H]+; 5-(dimethylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.033; JAAYHHGVUNISRC-PHDIDXHHSA-N; [M+H]+; methyl 2-[(3R,4S)-4-hydroxypyrrolidin-3-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; XYDFSCGFCFYWNY-RITPCOANSA-N; [M+H]+; methyl (2S,4R)-4-hydroxypiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.022; DTIMTCJMOWXMGT-UHFFFAOYSA-N; [M+H]+; 2-(butanoylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; ZWKAACPJQCCKND-UHFFFAOYSA-N; [M+H]+; 4-ethylmorpholine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; HJXDCFUIDHJETK-UHFFFAOYSA-N; [M+H]+; 3-(2-hydroxypropyl)-5-methyl-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; UIZGNXXVSZWKIJ-UHFFFAOYSA-N; [M+H]+; 4-ethylmorpholine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; MOPJMKPQANCZCZ-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylmorpholine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.990; TUWJYQVKXFSFFT-UHFFFAOYSA-N; [M+H]+; 3-(4-hydroxybutyl)-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.990; BGKAMYFJKFYFAJ-UHFFFAOYSA-N; [M+H]+; 2-(propan-2-ylideneamino)oxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; ROVDTLLPFWAZJC-UHFFFAOYSA-N; [M+H]+; 1-(3-hydroxypropyl)azetidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; UGNGLHKEESUVLW-RITPCOANSA-N; [M+H]+; (2S,4R)-4-ethoxypyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; GVPBPGUPXLOORE-UHFFFAOYSA-N; [M+H]+; 2-[5-(aminomethyl)oxolan-3-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; GLNHNBMSUXKDQT-UHFFFAOYSA-N; [M+H]+; 2-(2-amino-3-hydroxypropyl)cyclopropane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; XKZALAGWGNOWMN-UHFFFAOYSA-N; [M+H]+; 2-(6-methylmorpholin-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; ZAUFCVXOKIPCKG-UHFFFAOYSA-N; [M+H]+; methyl 5-hydroxypiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; VSVFGWZSIUDSCA-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyloxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; PYQKDNXCKYOCIW-NTSWFWBYSA-N; [M+H]+; (2R,6S)-6-(aminomethyl)oxane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; AFJIZTKWUYPYNE-UHFFFAOYSA-N; [M+H]+; methyl 4-hydroxypiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; AZFBPYNPITWILD-UHFFFAOYSA-N; [M+H]+; methyl 4-aminooxane-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; ABGLVXROVAEWNL-UHFFFAOYSA-N; [M+H]+; 4-methoxypiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; DJPOAMSLSHUTOZ-UHFFFAOYSA-N; [M+H]+; 5-methoxypiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; LCRFCICIBIZKQT-WDSKDSINSA-N; [M+H]+; (2S,4S)-4-methoxy-1-methylpyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; HZHAYCIWJCYRQI-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-1,2-dimethylpyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; KHSCSHCKVLUXAQ-NTSWFWBYSA-N; [M+H]+; (2R,5S)-5-(methoxymethyl)pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; JXSHAUHCKJCDDM-ZCFIWIBFSA-N; [M+H]+; [(8R)-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; VFNBELKXKOPBJT-JKUQZMGJSA-N; [M+H]+; methyl (1S,3R,4S)-3-amino-4-hydroxycyclopentane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; KSGBFAJYSBCOGG-UHFFFAOYSA-N; [M+H]+; 2-piperidin-4-yloxyacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; XTESLNLUWWTVGF-UHFFFAOYSA-N; [M+H]+; methyl 3-hydroxypiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.947; ZKLMTPLBEYYNKM-UHFFFAOYSA-N; [M+H]+; prop-2-enyl N-(3-hydroxypropyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.947; XLZJPHKIECMDPG-ZCFIWIBFSA-N; [M+H]+; (2R)-2-amino-2-(oxan-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.947; FEOYTKQMQQZJKE-UHFFFAOYSA-N; [M+H]+; 2-[3-(dimethylamino)oxetan-3-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.947; RLZNLTDCSCIJQI-UHFFFAOYSA-N; [M+H]+; 2-(3-methoxy-3-methylazetidin-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; SCRBWTUNKVHERJ-LURJTMIESA-N; [M+H]+; 2-[(3S)-3-methoxypyrrolidin-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; WJACJJKVFSLPJH-UHFFFAOYSA-N; [M+H]+; 4-methoxypiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; PTWKMUDNOPBYJO-UHFFFAOYSA-N; [M+H]+; ethyl morpholine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; RTBBWCJKGBZVGL-UHFFFAOYSA-N; [M+H]+; ethyl morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; AACMIVJLZDJLSX-UHFFFAOYSA-N; [M+H]+; methyl 4-hydroxypiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.941; CWULDSIGYRKXFB-UHFFFAOYSA-N; [M+H]+; ethyl 5-amino-4-oxopentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; QSZPPWBLNJFGIT-UHFFFAOYSA-N; [M+H]+; methyl 2-(hydroxymethyl)pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; KDBOBQCTMQRDBV-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-2-piperidin-4-ylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; QUQIHHCEASFDHL-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; UUNNQLNQGNNXKE-UHFFFAOYSA-N; [M+H]+; 3-(methoxymethyl)pyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; IMSUDXBVOIOXLR-UHFFFAOYSA-N; [M+H]+; 2-amino-3-(oxolan-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.931; MOQXTRBNZFLFOF-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)oxane-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; JLVXBPBNYIMTTB-UHFFFAOYSA-N; [M+H]+; 2-[2-(hydroxymethyl)pyrrolidin-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.921; VPVIIJOJZACMIE-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3-pyrrolidin-1-ylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; YOBNKFROEGVQPW-UHFFFAOYSA-N; [M+H]+; 8-azabicyclo[3.2.1]octane-1,2,7-triol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; FSMRMYVITPBGGD-UHFFFAOYSA-N; [M+H]+; 8-azabicyclo[3.2.1]octane-1,2,4-triol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; QRIAWCUEIMQLGG-UHFFFAOYSA-N; [M+H]+; 2-(4-aminooxan-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; PDUNXALRJLMKMJ-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(oxan-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; KKOAGCQXFCPYMD-UHFFFAOYSA-N; [M+H]+; 2-(3-aminooxan-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; XQSFETBRMIRLGH-UHFFFAOYSA-N; [M+H]+; 4-(methylamino)oxane-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; BWLLLFLCNYKKKB-UHFFFAOYSA-N; [M+H]+; methyl 1-(aminomethyl)-3-hydroxycyclobutane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; OTUZUAJROYEUAS-UHFFFAOYSA-N; [M+H]+; 2-amino-3-(oxolan-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; BGPODSGVEGWTLX-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(oxan-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; AACQYDPLUABCBS-UHFFFAOYSA-N; [M+H]+; methyl 1-amino-3-(hydroxymethyl)cyclobutane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.915; OQPHCUTUDXRLMX-UHFFFAOYSA-N; [M+H]+; 3,4a,5,6,7,7a-hexahydro-2H-[1,4]dioxino[2,3-c]pyrrol-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; PTFGUNZEOFOCIJ-UHFFFAOYSA-N; [M+H]+; methyl 3-(azetidin-3-yloxy)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; PVCYXJXAUBLSJG-UHFFFAOYSA-N; [M+H]+; methyl 2-morpholin-2-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; OUZLKVNNBZFQRE-UHFFFAOYSA-N; [M+H]+; 2-[methyl(2-methylpropanoyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; SUCYHGXECUURID-UHFFFAOYSA-N; [M+H]+; methyl 2-morpholin-3-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; IOZAQTKXFQIWIH-UHFFFAOYSA-N; [M+H]+; ethyl 2-(3-aminooxetan-3-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.885; HFBHOAHFRNLZGN-LURJTMIESA-N; [M+H]+; (2S)-2-formamido-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; CNRMSXVAIYXYCE-ZCFIWIBFSA-N; [M+H]+; methyl 2-[(3R)-pyrrolidin-3-yl]oxyacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; YJOXYLRKYMEXCI-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1-(methylamino)cyclobutane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; AZSGXPNBTJZERX-UHFFFAOYSA-N; [M+H]+; ethyl 3-aminooxolane-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; PRTHDMCLHDBANB-UHFFFAOYSA-N; [M+H]+; methyl 6-amino-5-oxohexanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; XEDZRASYGGJQCQ-UHFFFAOYSA-N; [M+H]+; methyl 4-methoxypyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; LEOFPCKFKFVFOL-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(1-methoxycyclobutyl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.831; NABSICLZLAXRSZ-UHFFFAOYSA-N; [M+H]+; methyl 1,4-oxazepane-6-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; NEFUSOJJTKMAEO-NTSWFWBYSA-N; [M+H]+; methyl (3S,5R)-5-aminooxane-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; HRHYRCUGGGPZNL-RITPCOANSA-N; [M+H]+; methyl (2S,6R)-6-methylmorpholine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; KTUOYOBLGIOGLU-PHDIDXHHSA-N; [M+H]+; methyl (2R,3R)-3-(aminomethyl)oxolane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; LYGKFJYDSSLHMS-UHFFFAOYSA-N; [M+H]+; methyl 1,4-oxazepane-7-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; QJATZDWCXVMGEL-WDSKDSINSA-N; [M+H]+; methyl (2S,4S)-4-aminooxane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; XLTPBSBNLKQLHB-AATRIKPKSA-N; [M+H]+; ethyl (E)-3-amino-3-ethoxyprop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; FXDMGMAWGOGVCR-UHFFFAOYSA-N; [M+H]+; methyl 1,4-oxazepane-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; SAPOPPYMFUJEBS-RITPCOANSA-N; [M+H]+; methyl (2R,3S)-2-methylmorpholine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.821; SMPHEDZQJBZERC-UHFFFAOYSA-N; [M+H]+; 3-[2-(2-hydroxyethoxy)ethoxy]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -35.210; MUNWAHDYFVYIKH; [M+H]+; Betonicine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.877; DJMIFDZBCUUQJN; [M+H]+; 3-Hydroxystachydrine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -74.128; YNOWULSFLVIUDH; [M+H]+; 3-Dehydrocarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -83.437; WTBNMEWVZFFAPJ; [M+H]+; Spectrum_001258
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.868; LCRFCICIBIZKQT; [M+H]+; 4-methoxy-1-methylproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.628; NRRIAWBEPOWFOG; [M+H]+; 4-hydroxy-1-methylpiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.863; ROVDTLLPFWAZJC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.301; BGKAMYFJKFYFAJ; [M+H]+; 2-(propan-2-ylideneamino)oxybutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.453; WZZMBPRDBKYFMA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.562; WEJKUVSYIGOBAR; [M+H]+; 2-Morpholinopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.565; QBAOJDDQEIVZJA; [M+H]+; 2-(methylamino)-5-oxohexanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.747; BWBSLKDWAOOBAL; [M+H]+; 4-amino-6-oxoheptanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.934; SMPHEDZQJBZERC; [M+H]+; Diethylene glycol mono-2-cyanoethyl ether
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.669; JPBFOLUCPZHDQU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.261; YUYHRSGXZZVNMS; [M+H]+; Oprea1_024812
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.414; BSILTUUPJBINLI; [M+H]+; methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.101; BWONBEUMAJFHTO; [M+H]+; Propanoic acid, 3-(dimethylamino)-2,2-dimethyl-3-oxo-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.252; KQOGWNKGUKQZHP; [M+H]+; methyl 4-hydroxypiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.829; LXEVWVMXUCHVCO; [M+H]+; methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.868; JMHQESARJMGVCZ; [M+H]+; ethyl 4-hydroxyprolinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.562; MVBWEDQLROJLNC; [M+H]+; methyl 5-(hydroxymethyl)prolinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.320; LTMOFXOWXXOMEZ; [M+H]+; Methyl Morpholinoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.331; SYOMWKCHPLIBRY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.503; SUCYHGXECUURID; [M+H]+; methyl-3-morpholinyl acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -255.812; ABGLVXROVAEWNL; [M+H]+; 4-methoxy-2-piperidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.188; RLKJCGBSXJCYIQ; [M+H]+; 3-Isobutyrylamino-propionic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.010; BSYFPUSAWVWWDG; [M+H]+; N-Acetylnorvaline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.306; MOPMNYGCKDMKSI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.196; WTXSKBFLNOWQNF; [M+H]+; methyl 3-hydroxypiperidinecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.176; XYDFSCGFCFYWNY; [M+H]+; methylhydroxypiperidinecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.290; ZAKAONRTRWRIJT; [M+H]+; ethyl 3-ethoxy-3-iminopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.630; HFBHOAHFRNLZGN; [M+H]+; n-formylleucin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.570; IONXXIKCTQHZNC; [M+H]+; ACMC-20lqov
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.750; KKBQWQJVUYTRDO; [M+H]+; methyl 5-hydroxypiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.632; IRIJLKLYPXLQSQ; [M+H]+; L-Norleucine, N-formyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.191; RXRVCSDDGFQDOJ; [M+H]+; 5-(Hydroxymethyl)-3-(1-methylethyl)oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.614; DNFNIHHMOVZOCZ; [M+H]+; methyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -283.820; SQDCKWZBSHPVFA; [M+H]+; (E,2S)-2-amino-6-hydroxy-5-methylhex-4-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.462; IHYJTAOFMMMOPX; [M+H]+; Acetylvaline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.041; CQHODIYUGCTFHA; [M+H]+; ethyl 4-hydroxyiminopentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.628; AACMIVJLZDJLSX; [M+H]+; methyl 4-hydroxypiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.967; QWMXDVGJULYARE; [M+H]+; morpholin-4-ylmethyl acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -294.962; UHJUDIZEJLVXPU; [M+H]+; 4-Hexenoic acid, 2-amino-6-hydroxy-4-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.212; VZDTVUQVDDMTIV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.372; TZZSWAXSIGWXOS; [M+H]+; 5-Acetamidopentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.875; ZKLMTPLBEYYNKM; [M+H]+; Allyl N-(3-hydroxypropyl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.810; DQWMCYRFSUZYJX; [M+H]+; ethyl 2-hydroxyiminopentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.322; PTWKMUDNOPBYJO; [M+H]+; 2-(Ethoxycarbonyl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -308.653; CMMYGCUEJWTBCG; [M+H]+; Enzacryl polyacetal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.345; DTIMTCJMOWXMGT; [M+H]+; Alanine,N-(1-oxobutyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.569; BYJPRUDFDZPCBH; [M+H]+; 2-[2-(N-Acryloylamino)ethoxy]ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.799; XLZJPHKIECMDPG; [M+H]+; 4''-Tetrahydropyranylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -327.353; RTBBWCJKGBZVGL; [M+H]+; Ethyl 4-morpholinecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -329.491; HOACIBQKYRHBOW; [M+H]+; N-sec-Valerylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.555; OTUZUAJROYEUAS; [M+H]+; 2-amino-3-(oxolan-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.270; QRIAWCUEIMQLGG; [M+H]+; 2-(4-aminooxan-4-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.085; BMZJPVSGERKRHP; [M+H]+; 3-amino-5-(hydroxymethyl)cyclohex-4-ene-1,2-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.560; JACJTGDBUDQHPY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.717; WQUVYJNPMXPWQT; [M+H]+; 2-Propenoic acid, 2-methyl-, 3-amino-2-hydroxypropyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.763; ZRQXMKMBBMNNQC; [M+H]+; Isovalerylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -358.344; YOBNKFROEGVQPW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -358.745; ROECQVJPXMAZDK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -359.882; WBWXNJQVIADNQY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -364.615; XOCBOVUINUHZJA; [M+H]+; Calystegin A3
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -365.227; QWHNMIXUSPUHGO; [M+H]+; 5-Methyl-5-nitrohexan-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.388; AXSWEYXUHSNDLV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.444; FSMRMYVITPBGGD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -391.353; SNEGRERRLGQPGA; [M+H]+; Cyclohexylserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -391.552; JSTZGHLHHVUXOT; [M+H]+; (2,5-dimethoxy-2H-furan-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -398.185; NYZBWOSRZJKQAI; [M+H]+; Valerylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -400.738; ZJARKWCZWLXHKE; [M+H]+; Oprea1_617516
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.598; MUNWAHDYFVYIKH; [M+H]+; Betonicine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -110.636; YNOWULSFLVIUDH; [M+H]+; 3-Dehydrocarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.237; WTBNMEWVZFFAPJ; [M+H]+; (3R,4S)-4-hydroxy-1,1-dimethylpyrrolidin-1-ium-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -153.677; MUNWAHDYFVYIKH; [M+H]+; Betonicine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.668; DJMIFDZBCUUQJN; [M+H]+; 3-Hydroxystachydrine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -172.454; CFNZJUUPIZLFLS; [M+H]+; [2-(2-Methoxy-ethoxy)-ethoxy]-acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -173.461; BGKAMYFJKFYFAJ; [M+H]+; 2-(Propan-2-ylideneamino)oxybutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -177.218; OUZLKVNNBZFQRE; [M+H]+; 2-[Isobutyryl(methyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.107; YUYHRSGXZZVNMS; [M+H]+; 3-Morpholinopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -183.322; SMPHEDZQJBZERC; [M+H]+; 3-[2-(2-Hydroxyethoxy)ethoxy]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -186.493; BWONBEUMAJFHTO; [M+H]+; 3-(Dimethylamino)-2,2-dimethyl-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.405; YNOWULSFLVIUDH; [M+H]+; 3-Dehydrocarnitine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H14N1O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 6.752
MS$FOCUSED_ION: PRECURSOR_M/Z 160.096867
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-1900000000-55a564eb35e3f7eaa3b2
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0651044 6.2958 58.065740 1.3950 1.26 0.8421 20 f{C3H8N1}/-0.37ppm,p-C4H6O3
  71.0602663 9.1984 71.060879 1.0977 3.07 -0.0351 21 ?
  72.0444002 79.9672 72.045007 0.4442 21.75 -0.0584 21 f{C3H6N1O1}/0.14ppm,p-C4H8O2
  86.0599252 13.4649 86.060392 1.2085 4.12 -0.0169 21 f{C4H8N1O1}/-1.34ppm,p-C3H6O2
  88.0756455 16.5965 88.076085 1.6577 3.00 0.9013 21 f{C4H10N1O1}/-0.51ppm,p-C3H4O2
  89.0708419 10.1691 89.071268 1.1002 2.78 0.3818 21 ?
  114.1025049 16.3288 114.102687 1.5512 4.48 0.0753 21 ?
  115.0501492 9.4441 115.050320 1.4515 3.48 -0.0571 21 ?
  142.0869889 6.0080 142.086892 1.8369 1.50 0.5765 16 f{C7H12N1O2}/5.16ppm,p-H2O1
  142.0974171 45.3701 142.097320 0.7952 12.39 -0.0130 21 ?
  142.1339024 5.7454 142.133805 2.7298 1.57 0.1176 17 ?
  143.0815263 49.8834 143.081429 0.7338 12.87 0.1052 21 ?
  160.0968120 999.0000 160.096703 0.2998 0.00 1.0000 21 f{C7H14N1O3}/-0.05ppm,p
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  58.065104 6.30 6
  71.060266 9.20 9
  72.044400 79.97 79
  86.059925 13.46 13
  88.075646 16.60 16
  89.070842 10.17 10
  114.102505 16.33 16
  115.050149 9.44 9
  142.086989 6.01 6
  142.097417 45.37 45
  142.133902 5.75 5
  143.081526 49.88 49
  160.096812 999.00 999
//
